Iszo Capital Management LP Avid Bioservices, Inc. Transaction History

Iszo Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$16.63 - $27.73 $36.7 Million - $61.2 Million	-2,208,313 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $2.87 Million - $4.74 Million	-138,648 Reduced 5.91%	2,208,313 $64.4 Million
Q1 2021 May 17, 2021	SELL	$11.86 - $21.77 $352,835 - $647,657	-29,750 Reduced 1.25%	2,346,961 $42.8 Million
Q4 2020 Feb 16, 2021	SELL	$7.25 - $11.76 $7.85 Million - $12.7 Million	-1,083,177 Reduced 31.31%	2,376,711 $27.4 Million
Q3 2020 Nov 17, 2020	BUY	$6.53 - $8.6 $22.6 Million - $29.8 Million	3,459,888 New	3,459,888 $26.4 Million
Q3 2020 Nov 16, 2020	SELL	$6.53 - $8.6 $23.2 Million - $30.5 Million	-3,548,032 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.11 - $6.78 $8.62 Million - $14.2 Million	-2,097,669 Reduced 37.16%	3,548,032 $23.3 Million
Q1 2020 May 15, 2020	BUY	$3.15 - $7.39 $4.49 Million - $10.5 Million	1,425,553 Added 33.78%	5,645,701 $28.9 Million
Q4 2019 Feb 14, 2020	SELL	$5.01 - $8.16 $1.58 Million - $2.57 Million	-314,546 Reduced 6.94%	4,220,148 $32.4 Million
Q3 2019 Nov 14, 2019	SELL	$5.07 - $7.08 $1.23 Million - $1.72 Million	-243,429 Reduced 5.09%	4,534,694 $24 Million
Q2 2019 Aug 14, 2019	BUY	$3.43 - $5.6 $5.26 Million - $8.58 Million	1,532,748 Added 47.23%	4,778,123 $26.8 Million
Q1 2019 May 15, 2019	SELL	$3.56 - $4.82 $869,789 - $1.18 Million	-244,323 Reduced 7.0%	3,245,375 $13.8 Million
Q4 2018 Feb 14, 2019	BUY	$4.04 - $6.75 $14.1 Million - $23.6 Million	3,489,698 New	3,489,698 $14.3 Million

182

65.1M

21.3K

110K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $661M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Iszo Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Iszo Capital Management LP with notifications on news.